Summary of Key Points
In July 2026, market rumors surfaced that China Everbright Bank was hiding nearly 20 billion yuan in bad debts. The issue stemmed from a discrepancy of nearly 20 billion yuan between the "non-performing loan balance" (50.742 billion yuan) and the "Stage 3 loans" (70.65 billion yuan) reported in its 2025 annual report. According to regulatory requirements, Stage 3 loans (which have already experienced credit impairment) should be classified as non-performing loans, but China Everbright did not fully account for them. The bank responded by stating that there were no undisclosed significant risks and established a market value management team to stabilize investor confidence. Nevertheless, the stock price still fell by more than 8% that year. Underlying problems include lax risk control, declining business performance, frequent changes in senior management, and a history of risky incidents, raising concerns about the transparency of its financial statements and its long-term development model.
Detailed Analysis
1. Where Did the Rumor Come From?
The discrepancy of 20 billion yuan arises from the different ways these two figures measure a bank's bad debt risk:
- Non-performing loans are those that are certain to be uncollectible or difficult to collect (e.g., those overdue for more than three months).
- Stage 3 loans are those that the bank believes may become uncollectible in the future based on new accounting standards (even if they are not yet overdue, due to deteriorating business conditions). According to regulatory requirements, Stage 3 loans should be classified as at least "substandard non-performing loans." However, China Everbright's total of Stage 3 loans at the end of 2025 (70.65 billion yuan) was 19.9 billion yuan higher than its non-performing loan balance (50.742 billion yuan), suggesting that nearly 20 billion yuan in potential bad debts were not recognized.
In comparison, similar figures for other banks such as CITIC Bank and China Merchants Bank are much closer. Only China Everbright had such a large discrepancy, which led to market skepticism.
2. Was the Bank's Handling Compliant?
China Everbright's approach did not violate the rules, but it was somewhat borderline:
The "Financial Asset Risk Classification Measures" issued by regulators in 2023 required that Stage 3 loans be classified as non-performing loans, but a transition period was granted, allowing existing loans to be classified according to the old rules until the end of 2025. China Everbright's 2025 annual report coincided with the end of this transition period, meaning some loans may not have been reclassified according to the new regulations. A risk control expert from a joint-stock bank explained that during the transition period, if a loan was overdue but secured by sufficient collateral and could still be collected, it might not be classified as non-performing. However, once the transition period ended, this flexibility would disappear, and the two figures should converge. Therefore, China Everbright's current practice is legal but not well-received by the market.
3. Why Is the Market Panicking?
The market's concern is not about compliance but rather two main issues:
- Transparency of financial statements: Could the large discrepancy be a deliberate attempt to hide bad debts? If 20 billion yuan in potential bad debts were not recognized, the actual quality of the bank's assets would be worse than what its reports suggest.
- Long-term risk control: Analysts point out that China Everbright has traditionally focused more on expanding its business scale rather than strengthening risk control. There have been frequent changes in senior management (seven presidents in the past decade), and new leaders may rush to achieve short-term results by approving loans without considering the risks. This, combined with historical issues such as large exposures to real estate and urban infrastructure projects, has led to an increase in bad debts.
This concern is reflected in the stock price: China Everbright's stock has fallen by more than 8% this year, with a 5.58% decline in 2025 (the fourth-worst performance among listed banks), and its price-to-book ratio has always been low among joint-stock banks, indicating a lack of market confidence in its risk management.
4. China Everbright's Existing Problems
In addition to the discrepancy, the bank faces several other significant issues:
- Declining business performance: Revenue and net profit both decreased by more than 6% in 2025, with another 8% drop in the first quarter of 2026. Weaker profitability means less funds available for writing off bad debts or setting up risk reserves (the reserve coverage ratio dropped from 174% to 162%).
- High potential risks: The ratio of loans under watch (1.85%) and overdue loans (2.13%) is higher than the non-performing loan rate (1.27%), indicating that these loans may become bad debts in the future, further accumulating risk.
- Historical risk issues: There have been serious mistakes in risk control, such as a fraud case at the Changchun branch in 2014 where 350 million yuan was stolen using a forged seal, and a 6.4 million yuan fine for concealing loan quality at the Shenzhen branch in 2025. Additionally, cases of corruption and fraudulent lending by executives highlight ongoing vulnerabilities in the risk control system.
- Instability in management: Seven presidents have been appointed in the past decade, with three chairmen changing in just three years. This frequent turnover makes it difficult to establish consistent risk control practices.
5. Can Market Value Management Stabilize the Stock Price?
China Everbright's establishment of a market value management team in July is a positive step, but its effectiveness is limited unless the underlying issues are addressed. Market value management typically involves actions like share repurchases and dividends, but the fundamental problems (bad debts, declining business performance, and weak risk control) must be resolved first. Without significant improvements, any short-term gains in the stock price will likely be temporary.
Conclusion
China Everbright's problems are not recent but result from a long-term focus on expanding its business scale at the expense of risk control. The 20-billion-yuan discrepancy is just a catalyst for broader doubts about the quality of its assets, the transparency of its financial statements, and its management capabilities. To restore investor confidence, fundamental changes in risk control and business practices are necessary. However, with frequent changes in senior management, achieving these changes will be challenging. Investors should remain cautious when considering banks with a history of risk control issues.
(Risk Warning: This article does not constitute investment advice; the market is subject to various risks.)